Highest Revenue
checkbookThese companies stand out for their exceptional revenue generation and represent the industry's top performers.
| name | Price | $ Change | % Change | Market Cap | Volume | Avg. Volume | arrow_downwardRevenue | Technicals | Dividend Y | ROI 1Y | Score language | Last 7 Days | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ENVBEnveric Biosciences | $1.27 | $0.06 | arrow_drop_up4.95% | $3.11M | 94.55K | 1.23 | _ | Neutralremove | - | -89.79% | |||||
CNSPCNS Pharmaceuticals | $1.08 | -$0.06 | arrow_drop_down5.24% | $4.11M | 151.26K | 1.11 | _ | Neutralremove | - | -99.79% | |||||
ALZNAlzamend Neuro | $3.58 | $0.02 | arrow_drop_up0.56% | $2.41M | 32.58K | 3.58 | _ | Neutralremove | - | -93.58% | |||||
FTFTFuture FinTech Group | $1.54 | -$0.07 | arrow_drop_down4.45% | $4.39M | 61.45K | 1.55 | _ | Neutralremove | - | -81.44% | |||||
REALRealReal | $5.23 | $0.01 | arrow_drop_up0.28% | $596.01M | 1.48M | 5.22 | _ | Neutralremove | - | 28.62% | |||||
TBMC TBMCTrailblazer Merger Corporation I - Class A Common Stock | $11.94 | $0.04 | arrow_drop_up0.33% | $53.40M | 101.35K | 11.86 | _ | Neutralremove | - | 10.69% | |||||
GLMDGalmed Pharmaceuticals Ltd | $1.37 | -$0.04 | arrow_drop_down2.83% | $2.84M | 98.44K | 1.37 | _ | Neutralremove | - | -71.19% | |||||
INMInMed Pharmaceuticals | $2.71 | $0.11 | arrow_drop_up4.00% | $3.55M | 39.59K | 2.79 | _ | Neutralremove | - | -61.53% | |||||
XRTXXORTX Therapeutics | $0.97 | -$0.02 | arrow_drop_down2.40% | $3.56M | 863.00 | 0.98 | _ | Neutralremove | - | -62.60% | |||||
CSSEChicken Soup For The Soul Entertainment | $0.00 | $0.00 | arrow_drop_up13.09% | $3.42M | 7.66K | 84.77K | _ | Buykeyboard_arrow_up | - | -96.99% | |||||
RWAY RWAYLRunway Growth Finance Corp. - 7.50% Notes due 2027 | $24.95 | -$0.05 | arrow_drop_down0.20% | $12.81B | 16.05K | 24.99 | _ | Neutralremove | - | 0.08% | |||||
ARTLArtelo Biosciences | $0.95 | -$0.00 | arrow_drop_down0.41% | $3.08M | 9.34K | 0.95 | _ | Neutralremove | - | -37.63% | |||||
HSCSHeart Test Laboratories | $3.95 | $0.02 | arrow_drop_up0.64% | $3.56M | 29.13K | 3.97 | _ | Neutralremove | - | -27.12% | |||||
AAMCAltisource Asset Management | $1.15 | -$0.15 | arrow_drop_down11.53% | $3.19M | 5.55K | 9.63K | _ | Neutralremove | - | -54.72% | |||||
NVVENuvve Holding | $0.88 | -$0.07 | arrow_drop_down8.22% | $3.40M | 712.08K | 0.90 | _ | Neutralremove | - | -87.14% | |||||
KMXCarMax | $62.49 | -$0.58 | arrow_drop_down0.91% | $10.34B | 1.88M | 62.12 | _ | Buykeyboard_arrow_up | - | -10.41% | |||||
IMPP IMPPImperial Petroleum | $2.74 | $0.27 | arrow_drop_up11.08% | $88.10M | 665.45K | 2.76 | _ | Neutralremove | - | -36.89% | |||||
AFIBAcutus Medical | $0.11 | -$0.01 | arrow_drop_down9.83% | $1.37M | 12.00K | 166.73K | _ | Buykeyboard_arrow_up | - | 115.68% | |||||
PCSAProcessa Pharmaceuticals | $0.23 | -$0.00 | arrow_drop_down0.86% | $2.93M | 9.36M | 0.27 | _ | Neutralremove | - | -87.01% | |||||
SONXSonendo | $0.05 | $0.00 | arrow_drop_up5.70% | $790.11K | 53.02K | 199.32K | _ | Sellkeyboard_arrow_down | - | -99.72% |
Showing 3041-3060 of 4978
Results per page:
About Highest Revenue
Enter the realm of stocks with the highest revenue, where companies are crushing their sales targets and achieving remarkable financial success. Revenue is a critical metric that measures a company's top-line performance, reflecting its ability to generate substantial income from its products or services.
Investors seeking promising opportunities often look to stocks with impressive revenue figures, as it indicates the company's market strength and demand for its offerings. These high revenue stocks can be attractive options for long-term investors seeking stable and prosperous ventures.
Discover the Power of Stocklytics Tools
Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.
See Stocklytics Tools